Research analytics domain
Identifiable extracts land only in a research processing domain with no direct write path back to production EHR APIs.
AC-4(2) requires processing domains as an enhancement to base AC-4 information flow enforcement. Base AC-4 establishes that flows must be authorized; this enhancement adds: Segment clinical, research, guest, IoMT, and corporate processing domains and allow only ordered, mediated flows between them. Healthcare delivery organizations rely on this to keep ePHI within approved clinical, billing, and research pathways.
Separate ePHI processing into protected domains and enforce ordered information flow between those domains.
How this control shows up in healthcare and HIPAA-covered environments.
Identifiable extracts land only in a research processing domain with no direct write path back to production EHR APIs.
Infusion pumps stay in an IoMT domain; only a broker may send limited ADT demographics — pumps cannot initiate sessions into the EHR database domain.
Patient/visitor Wi-Fi has no route to clinical domains; captive portal traffic stays in guest processing space.
Assessors look for operating evidence of Processing Domains on systems touching ePHI — screenshots, logs, and failed-test results — not only a policy paragraph referencing AC-4(2).
How this NIST control supports HIPAA Security Rule expectations.
VLANs help, but processing domains need enforced ordered flow policy between them — not just port labels.
SC-7 focuses on system boundaries; AC-4(2) emphasizes ordered information flow across processing domains.
Treat each trust environment (prod, nonprod, analytics) as a domain and control flows among them.
Related controls that commonly accompany AC-4(2).
Our auditors map NIST SP 800-53 controls to your HIPAA Security Rule program — policies, technical evidence, and audit readiness.